TRAZODONE HYDROCHLORIDE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Trazodone Hydrochloride, and when can generic versions of Trazodone Hydrochloride launch?
Trazodone Hydrochloride is a drug marketed by Accord Hlthcare, Aiping Pharm Inc, Alvogen, Am Therap, Apotex, Apotex Inc, Aurobindo Pharma, Crossmedika Sa, Granules, Graviti Pharms, Natco, Norvium Bioscience, Oxford Pharms, Pliva, Quantum Pharmics, Rising, Sun Pharm Industries, Teva, Teva Pharms Usa, Torrent, Usl Pharma, Watson Labs, and Zydus Pharms. and is included in thirty-two NDAs.
The generic ingredient in TRAZODONE HYDROCHLORIDE is trazodone hydrochloride. There are fourteen drug master file entries for this compound. Thirty-nine suppliers are listed for this compound. Additional details are available on the trazodone hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Trazodone Hydrochloride
A generic version of TRAZODONE HYDROCHLORIDE was approved as trazodone hydrochloride by APOTEX on March 25th, 1987.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for TRAZODONE HYDROCHLORIDE?
- What are the global sales for TRAZODONE HYDROCHLORIDE?
- What is Average Wholesale Price for TRAZODONE HYDROCHLORIDE?
Summary for TRAZODONE HYDROCHLORIDE
| US Patents: | 0 |
| Applicants: | 23 |
| NDAs: | 32 |
| Finished Product Suppliers / Packagers: | 39 |
| Raw Ingredient (Bulk) Api Vendors: | 134 |
| Clinical Trials: | 65 |
| Patent Applications: | 1,664 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for TRAZODONE HYDROCHLORIDE |
| DailyMed Link: | TRAZODONE HYDROCHLORIDE at DailyMed |
Recent Clinical Trials for TRAZODONE HYDROCHLORIDE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Simon Ducharme, MD | Phase 3 |
| Alzheimer's Drug Discovery Foundation | Phase 3 |
| University of New Mexico | Phase 4 |
Pharmacology for TRAZODONE HYDROCHLORIDE
| Drug Class | Serotonin Reuptake Inhibitor |
Medical Subject Heading (MeSH) Categories for TRAZODONE HYDROCHLORIDE
Anatomical Therapeutic Chemical (ATC) Classes for TRAZODONE HYDROCHLORIDE
Paragraph IV (Patent) Challenges for TRAZODONE HYDROCHLORIDE
| Tradename | Dosage | Ingredient | Strength | NDA | ANDAs Submitted | Submissiondate |
|---|---|---|---|---|---|---|
| OLEPTRO | Extended-release Tablets | trazodone hydrochloride | 150 mg and 300 mg | 022411 | 1 | 2010-10-18 |
US Patents and Regulatory Information for TRAZODONE HYDROCHLORIDE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sun Pharm Industries | TRAZODONE HYDROCHLORIDE | trazodone hydrochloride | TABLET;ORAL | 073137-002 | Mar 24, 1993 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Norvium Bioscience | TRAZODONE HYDROCHLORIDE | trazodone hydrochloride | TABLET;ORAL | 090514-001 | Jun 2, 2009 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Torrent | TRAZODONE HYDROCHLORIDE | trazodone hydrochloride | TABLET;ORAL | 202180-003 | Nov 27, 2013 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Zydus Pharms | TRAZODONE HYDROCHLORIDE | trazodone hydrochloride | TABLET;ORAL | 205253-004 | Oct 10, 2017 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Teva Pharms Usa | TRAZODONE HYDROCHLORIDE | trazodone hydrochloride | TABLET;ORAL | 071523-001 | Dec 11, 1987 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Torrent | TRAZODONE HYDROCHLORIDE | trazodone hydrochloride | TABLET;ORAL | 202180-004 | Nov 27, 2013 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
